FDA Drug Application (091426) for SPIRONOLACTONE by AMNEAL PHARMS

Back to FDA Applications sponsored by AMNEAL PHARMS

Application Number091426
Product Number001
FormTABLET;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSPIRONOLACTONE
Active IngredientSPIRONOLACTONE

Active IngredientCount
List of drugs with Active Ingredient SPIRONOLACTONE5


Back to FDA Applications sponsored by AMNEAL PHARMS